Scientific exchange · Dr. Rosa Garcia

24 Jul 2026 · Virtual · Dr. Rosa Garcia, Kyoto University Hospital · MSL James Whitfield · Lumeva

ReviewedVeeva CRMENG-0214MI request

Capture insight from this engagement

Location: Kyoto University Hospital
Therapeutic area: Neurology
Country: Japan
Stakeholder tier: Tier 3
Strategic objective: Not linked
Initiative: Not linked
MSL: JWJames WhitfieldSenior MSL, Oncology (US East)
Product: Lumeva (lumevarin)

Topics discussed

Chronic migraine data
Switching between CGRP agents
Dosing in hepatic impairment

Scientific content used

CGRP class review
Chronic migraine scientific platform

Questions raised

Is there guidance on switching from a monoclonal antibody?

Notes

Scientific exchange with general neurologist at Kyoto University Hospital. Discussed chronic migraine data, switching between cgrp agents, dosing in hepatic impairment.

Insights captured (0)

Capture insight

No insights captured from this engagement.

Review workflow

Draft
Submitted
3Reviewed

Review complete. Quality ratings and insights can now be used in aggregates.

Follow-ups

Send publication reprint

0 of 1 complete

Quality ratings

1–5, rated at review

Scientific relevance: 4
Strategic relevance: 5
Depth of exchange: 3
Actionability: 1

Data lineage

Source system: Veeva CRM
Sync: Veeva CRM · synced 2026-09-15 08:00 UTC
System of record: Veeva CRM
Record id: ENG-0214

Audit history (0)

All create, update and approval events for this record

No audit events in sample data